tiprankstipranks
Jade Biosciences (JBIO)
NASDAQ:JBIO
US Market
JBIO
Jade Biosciences
RESEARCH TOOLSreports
Want to see JBIO full AI Analyst Report?

Jade Biosciences (JBIO) Stock News & Sentiment

201 Followers
Arthur He Reiterates Buy on Jade with Unchanged $45 Price Target Ahead of Key JADE101 Phase 1 Data
Premium
Ratings
Arthur He Reiterates Buy on Jade with Unchanged $45 Price Target Ahead of Key JADE101 Phase 1 Data
7d ago
JBIO
Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target
Premium
Ratings
Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target
11d ago
JBIO
Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach
Premium
Ratings
Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach
11d ago
JBIO
Jade Biosciences Elevates Andrew King to R&D President
Premium
Company Announcements
Jade Biosciences Elevates Andrew King to R&D President
27d ago
8K
JBIO
Jade Biosciences Adopts 2026 Employment Inducement Stock Plan
Premium
Company Announcements
Jade Biosciences Adopts 2026 Employment Inducement Stock Plan
2M ago
8K
JBIO
3 High-Yield Dividend Stocks to Buy in Today’s Volatile Market, According to Analysts, 3/18/2026
Premium
Market News
3 High-Yield Dividend Stocks to Buy in Today’s Volatile Market, According to Analysts, 3/18/2026
2M ago
JBIO
TRIN
Jade: Differentiated IgAN Profile and Multi-Asset Upside Make $2B Peak Sales for JADE101 Look Conservative
Premium
Ratings
Jade: Differentiated IgAN Profile and Multi-Asset Upside Make $2B Peak Sales for JADE101 Look Conservative
2M ago
JBIO
More JBIO News >

JBIO News on the Web

Arthur He Reiterates Buy on Jade with Unchanged $45 Price Target Ahead of Key JADE101 Phase 1 Data
TipRanks News
Bullish
Jade Biosciences price target raised to $34 from $24 at Wedbush
TipRanks News
Neutral
Jade Biosciences price target raised to $32 from $23 at Guggenheim
TipRanks News
Bullish
Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target
TipRanks News
Bullish
Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Jade Biosciences files $600M mixed securities shelf
TipRanks News
Neutral
Jade Biosciences files to sell 39.54M shares of common stock for holders
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
JBIO
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JBIO’s Media Buzz Sentiment?
1 articles about JBIO were published this week. In an average week, 3.5 articles are published.
    What is JBIO’s weekly average amount of articles?
    In an average week, 3.5 articles about JBIO are published.
      What is JBIO’s News Sentiment?
      100% of articles about JBIO were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week